The strong expression of Trop‐2 on tumor cells, coupled with the absence of Trop‐2 expression in adjacent brain tissue and the ability of the SG payload SN‐38 to cross the blood–brain barrier,18, 19 may lead to a significant therapeutic opportunity. This evidence concerns the gene TACSTD2 and neoplasm.